Targeted Delivery of VEGF-siRNA to Glioblastoma Using Orientation-Controlled Anti-PD-L1 Antibody-Modified Lipid Nanoparticles
Ayaka Matsuo-Tani(Nagasaki University), Shigeru Kawakami(Nagasaki University), Naoya Kato(Zhejiang Chinese Medical University), Michiharu Yoshida(Nagasaki University), Hidefumi Mukai(RIKEN Center for Biosystems Dynamics Research), Mariko Kamiya(Nagasaki University), Takeshi Hiu(Nagasaki University), Makoto Matsumoto(Tottori University Hospital), Takayuki Matsuo(Nagasaki University), Yusuke Ushiroda(Nagasaki University), Hikaru Nakamura(Nagasaki University), Longjian Geng(Nagasaki University)
Cited by 5
Related Papers
A Toll-like receptor recognizes bacterial DNA
|Nature|2000|6.4k
HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY
|The Lancet|1986|2.4k
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
|Immunity|1998|2k
Essential role of Stat6 in IL-4 signalling
|Nature|1996|1.6k
Targeted disruption of the mouse <i>Stat3</i> gene leads to early embryonic lethality
|Proceedings of the National Academy of Sciences|1997|1.3k